ziihera
Generic: zanidatamab-hrii·Code: zanidatamab
ziihera: developed by 2 companies · 1 FDA decision. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Approved |
| Zymeworks Inc. (ZYME) | Approved |
FDA Decisions
Approval(JAZZ)
Frequently asked questions
Who is developing ziihera?
ziihera is being developed by Jazz Pharmaceuticals plc, Zymeworks Inc..
What is ziihera's latest FDA decision?
The most recent tracked FDA decision for ziihera is Approval, dated November 20, 2024.
Get deeper analysis on ziihera
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis